SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 118 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 1.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $30,000 | -53.1% | 10,000 | -28.6% | 0.01% | -50.0% |
Q3 2016 | $64,000 | -7.2% | 14,000 | +16.7% | 0.02% | -11.1% |
Q2 2016 | $69,000 | -4.2% | 12,000 | 0.0% | 0.02% | -5.3% |
Q1 2016 | $72,000 | -33.9% | 12,000 | 0.0% | 0.02% | -29.6% |
Q4 2015 | $109,000 | +62.7% | 12,000 | 0.0% | 0.03% | +58.8% |
Q3 2015 | $67,000 | – | 12,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Rokos Capital Management LLP | 6,474,348 | $11,394,852 | 0.84% |
WASATCH ADVISORS LP | 13,642,417 | $24,010,654 | 0.15% |
Avidity Partners Management LP | 2,470,000 | $4,347,200 | 0.14% |
Acrisure Capital Management, LLC | 75,832 | $133,464 | 0.14% |
Golden State Equity Partners | 135,765 | $238,946 | 0.13% |
Long Focus Capital Management, LLC | 1,072,000 | $1,886,720 | 0.11% |
KLK CAPITAL MANAGEMENT LLC | 44,323 | $78,008 | 0.10% |
CAXTON ASSOCIATES LP | 288,218 | $507,264 | 0.08% |
XTX Topco Ltd | 206,334 | $363,148 | 0.08% |
Rhenman & Partners Asset Management AB | 314,157 | $534,067 | 0.06% |